Ipilimumab

Drugs in R and D - United Kingdom
doi 10.2165/11584510-000000000-00000
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC

Related search

Überlebensvorteil Mit Ipilimumab

Best Practice Onkologie
Oncology
2010English

Ipilimumab-Induced Hypophysitis: MR Findings

Global Imaging Insights
2017English

Infliximab for IPILIMUMAB-Related Colitis--Letter

Clinical Cancer Research
Cancer ResearchOncology
2015English

Phase I Trial: SABR and Ipilimumab—Letter

Clinical Cancer Research
Cancer ResearchOncology
2017English

GM-CSF/Ipilimumab Combination Extends Melanoma Survival

Cancer Discovery
Oncology
2013English

Adjuvant Ipilimumab in High-Risk Uveal Melanoma

Cancers
Cancer ResearchOncology
2019English

Autoimmune Inflammatory Myopathy After Treatment With Ipilimumab

Canadian Journal of Neurological Sciences
MedicineNeurology
2009English

Bevacizumab Plus Ipilimumab in Patients With Metastatic Melanoma

Cancer immunology research
Cancer ResearchImmunology
2014English

CPC-078 Ipilimumab for Advanced Melanoma: Drug Use Review

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy